Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines.
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses.
Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir.
On the steps of cell-to-cell HIV transmission between CD4 T cells.
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.